Feature | November 04, 2010

Prostate MRI Analysis and Intervention Following Multiple Negative TRUS Biopsies: A Case Study

Multiplanar T2-weighted images and ADC map.

DynaCAD for Prostate and DynaTRIM interventional planning.

Prostate disease is primarily evaluated by using digital rectal examination (DRE) in combination with other clinical data including prostate-specific antigen (PSA) tests and pathologic information. These commonly used diagnostic tests have been shown to result in both high false positive and high false negative results. Additionally, the use of transrectal ultrasound-guided (TRUS) biopsy techniques for cancer detection can miss 20 percent or more of prostate cancers.

The use of DynaCAD for Prostate for image analysis and DynaTRIM (Trans-Rectal Interventional MRI) is a new option for evaluation of prostate disease, providing radiologists and urologists with another tool to diagnose their patients.

Clinical Case Study With Elevated PSA

A 67-year-old man presented with a PSA level of 5.4 ng/ml and no palpable abnormality on DRE. The first of two TRUS biopsies was performed with eight core samples. No malignancy was found. Due to elevated PSA, follow up was recommended.

Six months later, the second TRUS biopsy was performed with 12 core samples. Again, no malignancy was found and follow up was once again recommended. DRE was also performed with no palpable abnormalities. Since his PSA levels remained elevated, the patient was referred for a diagnostic MRI study. The examination was performed on a 3.0T MRI scanner with the body array coil in a dual-coil setup. Multiparametric imaging sequences were acquired including high-resolution, multiplanar T2-weighted anatomical images.

Diffusion-weighted images with b-values of 50, 500 and 800 were acquired and an ADC map was generated. The study was then imported to DynaCAD for Prostate for analysis and interpretation.

Image Results: A suspicious area was identified on axial T2. Based on these findings, MR-guided biopsy was recommended. MR-guided prostate biopsy was performed with DynaCAD for Prostate and DynaTRIM.

Diagnosis: Confirmed prostate pancer - Gleason 7 (75 percent in one core).

Summary: This patient, presenting with an elevated PSA, was able to benefit from this new imaging and interventional option where multiple TRUS-guided biopsies were performed with negative results. The clinician utilized DynaCAD for Prostate for the image analysis, which drew attention to suspicious areas and DynaTRIM for the targeted biopsy which resulted in a confirmed diagnosis.

This case study was supplied by Invivo Corp.

For more information: www.invivo.com, www.admetech.org and http://urology.jhu.edu/newsletter/prostate_cancer58.php

Related Content

Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Imaging | August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Carestream Launches MR Brain Perfusion and Diffusion Modules for Vue PACS
Technology | Advanced Visualization | August 16, 2017
Carestream Health recently introduced new MR (magnetic resonance) Brain Perfusion and MR Brain Diffusion modules that...
ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents
News | Contrast Media | August 15, 2017
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast...
MRI Reveals Striking Brain Differences in People with Genetic Autism

Example images for a control participant , a deletion carrier, and a duplication carrier. In the sagittal image of the deletion carrier, the thick corpus callosum, dens and craniocervical abnormality, and cerebellar ectopia are shown. For the duplication carrier, the sagittal image shows the thin corpus callosum and the axial image shows the increased ventricle size and decreased white matter volume. Image courtesy of the Radiological Society of North America (RSNA).

News | Neuro Imaging | August 09, 2017
August 9, 2017 — In the first major study of its kind, researchers using magnetic...
GE Healthcare's Signa Premier MRI Receives FDA 510(k) Clearance
Technology | Magnetic Resonance Imaging (MRI) | August 04, 2017
GE Healthcare announced Signa Premier, a new wide bore 3.0T magnetic resonance imaging (MRI) system, is now available...
brain with chronic traumatic injury
News | Magnetic Resonance Imaging (MRI) | August 02, 2017
Fighters are exposed to repeated mild traumatic brain injury (mTBI), which has been associated with neurodegenerative...
News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...
NIH-funded scientists have discovered that Parkinson’s disease increases the amount of “free” water in a particular brain area

NIH-funded scientists have discovered that Parkinson’s disease increases the amount of “free” water in a particular brain area. Image courtesy of David Vaillancourt, Ph.D., University of Florida.

News | Neuro Imaging | July 31, 2017
Scientists at the University of Florida have discovered a new method of observing the brain changes caused by Parkinson...
Overlay Init